Denali Therapeutics DNLI
NASDAQ DNLI
$20.81 -0.17 (-0.81%)
At close: Sep 29, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) Current Assets (2017 - 2026)

Updated

Denali Therapeutics (DNLI) recorded Current Assets of $753.93 million in Q2 2026, down 19.3% from $934.71 million a year earlier and down 26.3% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Current Assets (2017 - 2026) Analysis & Trends

At the end of FY2025, Denali Therapeutics reported Current Assets of $900.66 million, up 4.2% from FY2024.

  • Annual Current Assets has a five-year compound annual growth rate of -9.6% (FY2020 to FY2025).
  • Across earlier years, Current Assets came in at $864.44 million in FY2024 (-18.8%), $1.06 billion in FY2023 (-22.5%), $1.37 billion in FY2022 (+52.9%) and $897.23 million in FY2021 (-40.0%).
  • The Q2 2026 figure is the lowest quarterly Current Assets since Q2 2020.
  • On a year-over-year basis, Current Assets rose in four of the last eight quarters, with an average decline of 6.1%.
  • Peak year-over-year performance for Current Assets in the last five years was growth of 52.9% in Q4 2022, against a decline of 40.0% in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.02 billion (Q1 2026), $900.66 million (Q4 2025) and $882.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Denali Therapeutics 3.35 Bn 3.35 Bn 3.51 Mn 753.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 753.93 Mn
Mar 31, 2026 1.02 Bn
Dec 31, 2025 900.66 Mn
Sep 30, 2025 882.60 Mn
Jun 30, 2025 934.71 Mn
Mar 31, 2025 878.64 Mn
Dec 31, 2024 864.44 Mn
Sep 30, 2024 868.84 Mn
Jun 30, 2024 928.38 Mn
Mar 31, 2024 973.58 Mn
Dec 31, 2023 1.06 Bn
Sep 30, 2023 1.14 Bn
Jun 30, 2023 1.22 Bn
Mar 31, 2023 1.33 Bn
Dec 31, 2022 1.37 Bn
Sep 30, 2022 1.14 Bn
Jun 30, 2022 1.11 Bn
Mar 31, 2022 988.44 Mn
Dec 31, 2021 897.23 Mn
Sep 30, 2021 1.06 Bn
API Access

Denali Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=DNLI&period=max&api_key=YOUR_API_KEY